Advertisement

Reactions Weekly

, Volume 1730, Issue 1, pp 105–105 | Cite as

Crizotinib

Hepatotoxicity and drug resisitance: case report
Case report
  • 2 Downloads

Reference

  1. Tsakiri K, et al. Crizotinib failure in a TPM4- ALK-rearranged inflammatory myofibroblastic tumor with an emerging ALK kinase domain mutation. JCO Precision Oncology 2017: 1-7, No. 1, 2017. Available from: URL: http://doi.org/10.1200/PO.17.00015 - Greece

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations